The Efficacy of Conventionally Fractionated Radiation in the Management of Osseous Metastases from Metastatic Renal Cell Carcinoma
Open Access
- 9 January 2018
- journal article
- research article
- Published by Wiley in Journal of Oncology
- Vol. 2018, 1-7
Abstract
Background. There is little data regarding the effectiveness of palliative radiation with conventional fractionation for metastatic renal cell carcinoma (RCC), which has been described as radioresistant. We conducted a retrospective analysis of patients with metastatic bony disease from RCC treated with radiation therapy at our institution. Methods. Forty patients with histologically confirmed RCC with a total of 53 treatment courses were included. Pain response after radiotherapy was recorded and freedom from progression was generated using posttreatment radiographs. Patient data was analyzed to assess influence on local control. Results. Patients had a median age of 63. Median follow-up was 9.3 months. The most common radiation dose was 30 Gy in 10 fractions. Pain control after radiotherapy was achieved in 73.6% of patients. Increasing age was associated with nonresponse at the initial pain assessment post-RT . In lesions with initial pain response, nonclear cell histology was associated with increased pain recurrence and a shorter duration to pain recurrence . Radiographic control at 1 year was 62%. Conclusions. Pain response and control rates for osseous metastatic disease in RCC are comparable to other histologies when treated with conventional fractionation. These appear to be inferior to reported control rates from stereotactic treatments.
Keywords
This publication has 27 references indexed in Scilit:
- Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalitiesImmunoTargets and Therapy, 2013
- Tumor Control Outcomes After Hypofractionated and Single-Dose Stereotactic Image-Guided Intensity-Modulated Radiotherapy for Extracranial Metastases From Renal Cell CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local controlRadiation Oncology, 2011
- The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT)Biomedical Imaging and Intervention Journal, 2007
- A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinomaActa Oncologica, 2006
- A phase II trial of palliative radiotherapy for metastatic renal cell carcinomaCancer, 2005
- Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone MetastasesJNCI: Journal of the National Cancer Institute, 2005
- Skeletal Complications in Patients with Bone Metastases from Renal Cell Carcinoma and Therapeutic Benefits of Zoledronic AcidClinical Cancer Research, 2004
- Pain control by ionizing radiation of bone metastasisThe International Journal of Developmental Biology, 2004
- Palliative Irradiation for Focally Symptomatic Metastatic Renal Cell CarcinomaJournal of Urology, 1997